ProteoTech Alternatives & Competitors
12 companies similar to ProteoTech — Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996
Companies similar to ProteoTech
Amyl Therapeutics
Restoring clarity in amyloid diseases
Liege, Belgium
Neurotrope Inc.
Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...
New York, United States
Libra Therapeutics
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
San Diego, United States
Cognoptix
The Eye Scan for Alzheimer's Early Insight
Marlborough, United State...
Rival Readout
Competing with ProteoTech? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
United States
Asceneuron SA
Targeting the root cause of neurodegeneration
Lausanne, Switzerland
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
Cambridge, United Kingdom
Proclara Biosciences
Pioneering therapies to combat neurodegenerative diseases with innovative protein disaggre...
Pangolin Therapeutics, Inc.
New therapeutic agents targeting intrinsically disordered proteins.
United States
Genmedica Therapeutics
Pioneering the path towards disease-modifying solutions for type 2 diabetes
-logo.jpg "Kineta (Reverse Merger With Yumanity Therapeutics)"){kind=logo}
Kineta (Reverse Merger With Yumanity Therapeutics)
Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfo...
ALSP, Inc.
Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...
La Jolla, United States
About ProteoTech
ProteoTech is a US-based pharmaceutical company founded in 1996, dedicated to advancing therapeutics and diagnostics for amyloid diseases. The company's product lineup includes Exebryl-1, which targets the prevention of beta-amyloid protein formation, PeptiClere for Alzheimer's treatment, Synuclere for Parkinson's dise...
Pharmaceuticals, Therapeutics, Diagnostics, Amyloid Diseases, Alzheimer's Disease, Parkinson's Disease, Drug Development, Molecule Compound, Medical Research, Nasal Spray, Systemic Amyloidosis, Type 2 Diabetes, Proteins, Neurodegenerative Diseases
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ProteoTech: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ProteoTech on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
